Upstream / Downstream

pathwayImage

Explore pathways related to this product.

Antibody Guarantee

CST Antibody Performance Guarantee

LEARN MORE  

To Purchase # 8907SC

8907SC 10 µg (With Carrier)
8907SF 10 µg (Carrier Free)
8907LC 50 µg (With Carrier)
8907LF 50 µg (Carrier Free)

To get local purchase information on this product, click here

Questions?

Find answers on our FAQs page.

ANSWERS  

Visit PhosphoSitePlus®

PTM information and tools available.

LEARN MORE

Source / Purification

Recombinant human IL-2 (hIL-2) Ala21-Thr153 (Accession #NM_000586) was produced in E. coli at Cell Signaling Technology.

Product Description

Purity:

>98% as determined by SDS-PAGE of 6 μg reduced (+) and non-reduced (-) recombinant hIL-2. All lots are greater than 98% pure.


Molecular Formula:

Recombinant hIL-2 does not have a Met on the amino terminus and has a calculated MW of 15,418. DTT-reduced and non-reduced protein migrate as 14 kDa polypeptides with non-reduced protein having slightly greater mobility due to an intramolecular cystine. The expected amino-terminal APTSS of recombinant hIL-2 was verified by amino acid sequencing.


Bioactivity:

The bioactivity of recombinant hIL-2 was determined in a CTLL-2 cell proliferation assay. The ED50 of each lot is between 0.1 - 0.2 ng/ml.


Endotoxin:

Less than 0.01 ng endotoxin/1 μg hIL-2.


Product Usage Information

Formulation:

With carrier: Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.2 containing 20 μg BSA per 1 μg hIL-2. Carrier free: Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.2.


Storage: Stable in lyophilized state at 4°C for 1 year after receipt. Sterile stock solutions reconstituted with carrier protein are stable at 4°C for 2 months and at -20°C for 6 months. Avoid repeated freeze-thaw cycles.Maintain sterility. Storage at -20°C should be in a manual defrost freezer.

IL-2 is a T cell stimulatory cytokine best known for inducing T cell proliferation and NK cell proliferation and activation (1,2). IL-2 also promotes peripheral development of Treg cells (4, 5). Conversely, IL-2 is involved in activation induced cell death (AICD) that is observed post T cell expansion by increasing levels of Fas on CD4+ T cells (3). The effects of IL-2 are mediated through a trimeric receptor complex consisting of IL-2Rα, IL-2Rβ and the common gamma chain, γc (1,2). IL-2 Rα binds exclusively to IL-2 with low affinity and increases binding affinity of the whole receptor complex including IL-2Rβ and γc subunits. IL-2Rβ is also used by IL-15 (1,2). The common γc is used by other cytokines including IL-4, IL-7, IL-9, IL-15, and IL-21 (1,2). Binding of IL-2 initiates signaling cascades involving Jak1, Jak3, Stat5 and the PI3K/Akt pathways (1,2).


1.  Ma, A. et al. (2006) Annu Rev Immunol 24, 657-79.

2.  Gaffen, S.L. and Liu, K.D. (2004) Cytokine 28, 109-23.

3.  Fehérvari, Z. et al. (2006) Trends Immunol 27, 109-11.

4.  Antony, P.A. et al. (2006) J Immunol 176, 5255-66.

5.  Jaleco, S. et al. (2003) J Immunol 171, 61-8.


Entrez-Gene Id 3558
Swiss-Prot Acc. P60568


For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.